Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version

Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever



Principal Investigator
Brenda Everett & Robin Hillier

PI Address
Principal Investigator: Brenda Everett
Harborview Injury Prevention and Research Center
Principal Investigator: Robin Hillier
Harborview Injury Prevention and Research Center

Contact Email
hillr@uw.edu

Sponsor



Trial Phase:Phase III
Study Size Planned:100
Centers Planned:1
Max Time from onset:24 Hours
Max Age:85
Min Age:18
ISRCTN# NCT00890604
Status:
This study is currently recruiting participants.

Purpose:
To evaluate if 1) A standardized, step-wise approach to temperature management using a Normothermia Protocol is successful in achieving and maintaining normal temperature in Neurosurgical ICU patients; and 2) If maintenance of normal temperature will be associated with fewer episodes of diminished responsiveness in their neurological exams as evidenced by a measure of depth of coma, as measured by the Glasgow Coma Score (GCS) compared to a control group treated according to usual care.

Interventions:
Aspirin
Antiplatelet agent; inhibits thromboxane A2; antipyretic
Cooling blanket
lower body temperature
Hydrogel Cooling Pads
lower body temperature with cold applications to extremities
Ibuprofen
a non-steroidal anti-inflammatory drug (NSAID). It is used for relief of symptoms of arthritis, primary dysmenorrhea, fever, and as an analgesic, especially where there is an inflammatory component. Ibuprofen is known to have an antiplatelet effect, though it is relatively mild and short-lived when compared with that of aspirin or other better-known antiplatelet drugs.
Physical Cooling Measures
fan, ice packs
Standard Medical Care
per the National Guidelines for Stroke.

Location(s):
Washington

Year Started: 2009

Design:
Interventional, Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study.

Inclusion Criteria
Temperature > 38.3 Celsius; meet brain injury criteria:
traumatic brain injury with Glasgow Coma Scale score of 8 or less, Subarachnoid hemorrhage without vasospasm- Hunt and Hess grade III and below, Subarachnoid hemorrhage with vasospasm; first febrile episode; English speaking.

Exclusion Criteria
Skin breakdown; bleeding disorders; increased risk for clotting; ongoing seizure activity; allergy to medications used in the study; prisoners; pregnancy.

Patient Involvement:
Patient will be randomized to one of two arms: Usual standard of care per their physician or the experimental arm receiving A standardized, step-wise approach to temperature management using a Normothermia Protocol.

Primary Outcome:
Glasgow Coma Score

Secondary Outcome:
temperature; length of stay

Comments:
Scientific Name: Outcomes Associated With the Application of the Normothermia Protocol in Patients With Severe Neurological Insult and Fever

Source of Information:
ClinicalTrials.gov

Web Links and Publications:
Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever
ClinicalTrials.gov

This information last updated on: 5/25/2010

Reviewed on: 05/25/2010.

UID: 974

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2010 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, March 12, 2010